Brief: Tonix Pharmaceuticals - Amends Sales Agreement With Alliance Global Partners - SEC Filing
21/11/2025 22:01
Nov 21 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O: TONIX PHARMACEUTICALS - AMENDS SALES AGREEMENT WITH ALLIANCE GLOBAL PARTNERS - SEC FILING TONIX PHARMACEUTICALS - INCREASES OFFERING PRICE TO $400 MILLION - SEC FILING Further company coverage: TNXP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tonix Pharmaceuticals Holding
See all newsBrief: Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya
Brief: Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement For Tonmya®
Tonix Pharmaceuticals Holding Corp. reports results for the quarter ended June 30 - Earnings Summary
Tonix Q2 revenue rises sharply on TONMYA launch
Tonix Pharmaceuticals Holding Corp. expected to post a loss of $2.70 a share - Earnings Preview